Effect of antioxidants coenzyme Q10 and β‑carotene on the cytotoxicity of vemurafenib against human malignant melanoma
- Authors:
- Changkun Hu
- Yuan Huang
- Peixiao Luo
- Yixin Yang
-
Affiliations: Division of Biology, Kansas State University, Manhattan, KS 66506, USA, Department of Hematopathology, Anqing Municipal Hospital, Anqing, Anhui 246004, P.R. China, School of Natural Sciences, College of Science and Technology, Wenzhou Kean University, Wenzhou, Zhejiang 325035, P.R. China - Published online on: January 14, 2021 https://doi.org/10.3892/ol.2021.12469
- Article Number: 208
-
Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Sandru A, Voinea S, Panaitescu E and Blidaru A: Survival rates of patients with metastatic malignant melanoma. J Med Life. 7:572–576. 2014.PubMed/NCBI | |
Karimkhani C, Green AC, Nijsten T, Weinstock MA, Dellavalle RP, Naghavi M and Fitzmaurice C: The global burden of melanoma: Results from the global burden of disease study 2015. Br J Dermatol. 177:134–140. 2017. View Article : Google Scholar : PubMed/NCBI | |
Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, Stang A, Roesch A and Ugurel S: Melanoma. Lancet. 392:971–984. 2018. View Article : Google Scholar : PubMed/NCBI | |
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI | |
Boniol M, Autier P, Boyle P and Gandini S: Cutaneous melanoma attributable to sunbed use: Systematic review and meta-analysis. BMJ. 345:e47572012. View Article : Google Scholar : PubMed/NCBI | |
Liu F, Yang X, Geng M and Huang M: Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy. Acta Pharm Sin B. 8:552–562. 2018. View Article : Google Scholar : PubMed/NCBI | |
Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, et al: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 364:2507–2516. 2011. View Article : Google Scholar : PubMed/NCBI | |
Menzies AM, Haydu LE, Visintin L, Carlino MS, Howle JR, Thompson JF, Kefford RF, Scolyer RA and Long GV: Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma. Clin Cancer Res. 18:3242–3249. 2012. View Article : Google Scholar : PubMed/NCBI | |
Sanchez JN, Wang T and Cohen MS: BRAF and MEK Inhibitors: Use and resistance in BRAF-mutated cancers. Drugs. 78:549–566. 2018. View Article : Google Scholar : PubMed/NCBI | |
Livingstone E, Zimmer L, Piel S and Schadendorf D: PLX4032: Does it keep its promise for metastatic melanoma treatment? Expert Opin Investig Drugs. 19:1439–1449. 2010. View Article : Google Scholar : PubMed/NCBI | |
Bradish JR, Montironi R, Lopez-Beltran A, Post KM, MacLennan GT and Cheng L: Towards personalized therapy for patients with malignant melanoma: Molecular insights into the biology of BRAF mutations. Future Oncol. 9:245–253. 2013. View Article : Google Scholar : PubMed/NCBI | |
Hamid O, Cowey CL, Offner M, Faries M and Carvajal RD: Efficacy, Safety, and tolerability of approved combination BRAF and MEK inhibitor regimens for BRAF-mutant melanoma. Cancers (Basel). 11:16422019. View Article : Google Scholar | |
Barrueto L, Caminero F, Cash L, Makris C, Lamichhane P and Deshmukh RR: Resistance to checkpoint inhibition in cancer immunotherapy. Transl Oncol. 13:1007382020. View Article : Google Scholar : PubMed/NCBI | |
Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J, Hamid O, Schuchter L, Cebon J, Ibrahim N, et al: Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med. 367:1694–1703. 2012. View Article : Google Scholar : PubMed/NCBI | |
Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, O'Dwyer PJ, Lee RJ, Grippo JF, Nolop K and Chapman PB: Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 363:809–819. 2010. View Article : Google Scholar : PubMed/NCBI | |
Chang CY, Park H, Malone DC, Wang CY, Wilson DL, Yeh YM, Van Boemmel-Wegmann S and Lo-Ciganic WH: Immune checkpoint inhibitors and immune-related adverse events in patients with advanced melanoma: A systematic review and network meta-analysis. JAMA Netw Open. 3:e2016112020. View Article : Google Scholar : PubMed/NCBI | |
Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey CL, Lao CD, Wagstaff J, Schadendorf D, Ferrucci PF, et al: Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 377:1345–1356. 2017. View Article : Google Scholar : PubMed/NCBI | |
Ascierto PA, Del Vecchio M, Robert C, Mackiewicz A, Chiarion-Sileni V, Arance A, Lebbé C, Bastholt L, Hamid O, Rutkowski P, et al: Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: A randomised, double-blind, multicentre, phase 3 trial. Lancet Oncol. 18:611–622. 2017. View Article : Google Scholar : PubMed/NCBI | |
Hodi FS, Chesney J, Pavlick AC, Robert C, Grossmann KF, McDermott DF, Linette GP, Meyer N, Giguere JK, Agarwala SS, et al: Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial. Lancet Oncol. 17:1558–1568. 2016. View Article : Google Scholar : PubMed/NCBI | |
Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, et al: Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med. 372:2521–2532. 2015. View Article : Google Scholar : PubMed/NCBI | |
Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD, Cowey CL, Schadendorf D, Wagstaff J, Dummer R, et al: Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 381:1535–1546. 2019. View Article : Google Scholar : PubMed/NCBI | |
Dummer R, Ascierto PA, Nathan P, Robert C and Schadendorf D: Rationale for immune checkpoint inhibitors plus targeted therapy in metastatic melanoma: A review. JAMA Oncol. Sep 24–2020.doi: 10.1001/jamaoncol.2020.4401 (Epub ahead of print). View Article : Google Scholar | |
Godic A, Poljsak B, Adamic M and Dahmane R: The role of antioxidants in skin cancer prevention and treatment. Oxid Med Cell Longev. 2014:8604792014. View Article : Google Scholar : PubMed/NCBI | |
Ahmad R, Wani A and Ahsan H: Role of antioxidants in pathophysiology. J Med Erudite. 2:9–15. 2013. | |
Bairati I, Meyer F, Gélinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Têtu B, Harel F, Mâsse B, et al: A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst. 97:481–488. 2005. View Article : Google Scholar : PubMed/NCBI | |
Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS and Lele RD: Free radicals and antioxidants in human health: Current status and future prospects. J Assoc Physicians India. 52:794–804. 2004.PubMed/NCBI | |
Ma J, Zhang Q, Chen S, Fang B, Yang Q, Chen C, Miele L, Sarkar FH, Xia J and Wang Z: Mitochondrial dysfunction promotes breast cancer cell migration and invasion through HIF1alpha accumulation via increased production of reactive oxygen species. PLoS One. 8:e694852013. View Article : Google Scholar : PubMed/NCBI | |
Kvam E and Tyrrell RM: The role of melanin in the induction of oxidative DNA base damage by ultraviolet A irradiation of DNA or melanoma cells. J Invest Dermatol. 113:209–213. 1999. View Article : Google Scholar : PubMed/NCBI | |
Sun L, Guo Y, Zhang Y and Zhuang Y: Antioxidant and Anti-tyrosinase activities of phenolic extracts from rape bee pollen and inhibitory melanogenesis by cAMP/MITF/TYR pathway in B16 mouse melanoma cells. Front Pharmacol. 8:1042017. View Article : Google Scholar : PubMed/NCBI | |
Umemura T, Naoi M, Takahashi T, Fukui Y, Yasue T, Ohashi M and Nagatsu T: Cytotoxic effect of 1-methyl-4-phenylpyridinium ion on human melanoma cell lines, HMV–II and SK-MEL-44, is dependent on the melanin contents and caused by inhibition of mitochondrial electron transport. Biochem Med Metab Biol. 44:51–58. 1990. View Article : Google Scholar : PubMed/NCBI | |
Oliveira S, Coelho P, Prudêncio C, Vieira M, Soares R, Guerreiro SG and Fernandes R: Melanoma and obesity: Should antioxidant vitamins be addressed? Life Sci. 165:83–90. 2016. View Article : Google Scholar : PubMed/NCBI | |
Sarangarajan R, Meera S, Rukkumani R, Sankar P and Anuradha G: Antioxidants: Friend or foe? Asian Pac J Trop Med. 10:1111–1116. 2017. View Article : Google Scholar : PubMed/NCBI | |
Yang G, Yan Y, Ma Y and Yang Y: Vitamin C at high concentrations induces cytotoxicity in malignant melanoma but promotes tumor growth at low concentrations. Mol Carcinog. 56:1965–1976. 2017. View Article : Google Scholar : PubMed/NCBI | |
Le Gal K, Ibrahim MX, Wiel C, Sayin VI, Akula MK, Karlsson C, Dalin MG, Akyürek LM, Lindahl P, Nilsson J and Bergo MO: Antioxidants can increase melanoma metastasis in mice. Sci Transl Med. 7:308re3082015. View Article : Google Scholar | |
Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, DeBerardinis RJ and Morrison SJ: Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 527:186–191. 2015. View Article : Google Scholar : PubMed/NCBI | |
Poljsak B and Milisav I: The role of antioxidants in cancer, friends or foes? Curr Pharm Des. 24:5234–5244. 2018. View Article : Google Scholar : PubMed/NCBI | |
Yamamoto Y and Yamashita S: Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress. Mol Aspects Med. 18 (Suppl):S79–S84. 1997. View Article : Google Scholar : PubMed/NCBI | |
Saha SP and Whayne TF Jr: Coenzyme Q-10 in human health: Supporting evidence? South Med J. 109:17–21. 2016. View Article : Google Scholar : PubMed/NCBI | |
Overvad K, Diamant B, Holm L, Holmer G, Mortensen SA and Stender S: Coenzyme Q10 in health and disease. Eur J Clin Nutr. 53:764–770. 1999. View Article : Google Scholar : PubMed/NCBI | |
Folkers K, Osterborg A, Nylander M, Morita M and Mellstedt H: Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer. Biochem Biophys Res Commun. 234:296–299. 1997. View Article : Google Scholar : PubMed/NCBI | |
Folkers K: The potential of coenzyme Q10 (NSC-140865) in cancer treatment. Cancer Chemother Rep. 2(4): 19–22. 1974. | |
Rusciani L, Proietti I, Rusciani A, Paradisi A, Sbordoni G, Alfano C, Panunzi S, De Gaetano A and Lippa S: Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. J Am Acad Dermatol. 54:234–241. 2006. View Article : Google Scholar : PubMed/NCBI | |
Jolliet P, Simon N, Barré J, Pons JY, Boukef M, Paniel BJ and Tillement JP: Plasma coenzyme Q10 concentrations in breast cancer: Prognosis and therapeutic consequences. Int J Clin Pharmacol Ther. 36:506–509. 1998.PubMed/NCBI | |
El-Attar E, Kamel A, Karmouty A, Wehida N, Nassra R, El Nemr M and Kandil NS: Assessment of serum CoQ10 levels and other antioxidant markers in breast cancer. Asian Pac J Cancer Prev. 21:465–471. 2020. View Article : Google Scholar : PubMed/NCBI | |
Lund EL, Quistorff B, Spang-Thomsen M and Kristjansen PE: Effect of radiation therapy on small-cell lung cancer is reduced by ubiquinone intake. Folia Microbiol (Praha). 43:505–506. 1998. View Article : Google Scholar : PubMed/NCBI | |
Lockwood K, Moesgaard S and Folkers K: Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochem Biophys Res Commun. 199:1504–1508. 1994. View Article : Google Scholar : PubMed/NCBI | |
Roffe L, Schmidt K and Ernst E: Efficacy of coenzyme Q10 for improved tolerability of cancer treatments: A systematic review. J Clin Oncol. 22:4418–4424. 2004. View Article : Google Scholar : PubMed/NCBI | |
Coenzyme Q10 (PDQ(R)): Health Professional Version. PDQ Cancer Information Summaries Bethesda, MD: 2002 | |
Hong SK, Starenki D, Wu PK and Park JI: Suppression of B-RafV600E melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinone. Cancer Biol Ther. 18:106–114. 2017. View Article : Google Scholar : PubMed/NCBI | |
Diplock AT: Safety of antioxidant vitamins and beta-carotene. Am J Clin Nutr. 62 (Suppl 6):1510S–1516S. 1995. View Article : Google Scholar : PubMed/NCBI | |
Fiedor J and Burda K: Potential role of carotenoids as antioxidants in human health and disease. Nutrients. 6:466–488. 2014. View Article : Google Scholar : PubMed/NCBI | |
Guruvayoorappan C and Kuttan G: Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells. Integr Cancer Ther. 6:258–270. 2007. View Article : Google Scholar : PubMed/NCBI | |
Pradeep CR and Kuttan G: Effect of beta-carotene on the inhibition of lung metastasis in mice. Phytomedicine. 10:159–164. 2003. View Article : Google Scholar : PubMed/NCBI | |
IARC Working Group on the Evaluation of Cancer-Preventive Agents, . IARC Handbooks of Cancer Prevention. Carotenoids; Lyon; 1998 | |
Mayne ST, Handelman GJ and Beecher G: Beta-carotene and lung cancer promotion in heavy smokers-a plausible relationship? J Natl Cancer Inst. 88:1513–1515. 1996. View Article : Google Scholar : PubMed/NCBI | |
Stryker WS, Stampfer MJ, Stein EA, Kaplan L, Louis TA, Sober A and Willett WC: Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am J Epidemiol. 131:597–611. 1990. View Article : Google Scholar : PubMed/NCBI | |
Epstein JH: Effects of beta-carotene on ultraviolet induced cancer formation in the hairless mouse skin. Photochem Photobiol. 25:211–213. 1977. View Article : Google Scholar : PubMed/NCBI | |
Black HS: Radical interception by carotenoids and effects on UV carcinogenesis. Nutr Cancer. 31:212–217. 1998. View Article : Google Scholar : PubMed/NCBI | |
Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 330:1029–1035. 1994. View Article : Google Scholar : PubMed/NCBI | |
Middha P, Weinstein SJ, Mannisto S, Albanes D and Mondul AM: β-carotene supplementation and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: The role of tar and nicotine. Nicotine Tob Res. 21:1045–1050. 2019. View Article : Google Scholar : PubMed/NCBI | |
Zhang YP, Chu RX and Liu H: Vitamin A intake and risk of melanoma: A meta-analysis. PLoS One. 9:e1025272014. View Article : Google Scholar : PubMed/NCBI | |
Chen HY, Huang SM, Yang CM and Hu ML: Diverse effects of β-carotene on secretion and expression of VEGF in human hepatocarcinoma and prostate tumor cells. Molecules. 17:3981–3988. 2012. View Article : Google Scholar : PubMed/NCBI | |
Jang M, Kim SS and Lee J: Cancer cell metabolism: Implications for therapeutic targets. Exp Mol Med. 45:e452013. View Article : Google Scholar : PubMed/NCBI | |
Wang HM, Yang HL, Thiyagarajan V, Huang TH, Huang PJ, Chen SC, Liu JY, Hsu LS, Chang HW and Hseu YC: Coenzyme Q0 enhances ultraviolet b-induced apoptosis in human estrogen receptor-positive breast (MCF-7) cancer cells. Integr Cancer Ther. 16:385–396. 2017. View Article : Google Scholar : PubMed/NCBI | |
Chen HY, Yang CM, Chen JY, Yueh TC and Hu ML: Multicarotenoids at physiological levels inhibit metastasis in human hepatocarcinoma SK-Hep-1 cells. Nutr Cancer. 67:676–686. 2015. View Article : Google Scholar : PubMed/NCBI | |
McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, et al: Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 1773:1263–1284. 2007. View Article : Google Scholar : PubMed/NCBI | |
Lobo V, Patil A, Phatak A and Chandra N: Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 4:118–126. 2010. View Article : Google Scholar : PubMed/NCBI | |
Bowman BA and Russell RM: Present Knowledge in Nutrition. ILSI Press; Washington D.C.: 2006 | |
Hajhashemi V, Vaseghi G, Pourfarzam M and Abdollahi A: Are antioxidants helpful for disease prevention? Res Pharm Sci. 5:1–8. 2010.PubMed/NCBI | |
Salganik RI: The benefits and hazards of antioxidants: Controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr. 20 (Suppl 5):464S–475S. 2001. View Article : Google Scholar : PubMed/NCBI | |
Prasad KN, Kumar A, Kochupillai V and Cole WC: High doses of multiple antioxidant vitamins: Essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr. 18:13–25. 1999. View Article : Google Scholar : PubMed/NCBI | |
Prasad KN, Cole WC, Kumar B and Prasad KC: Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies. J Am Coll Nutr. 20 (5 Suppl):450S–463S; discussion 473S-475S. 2001. View Article : Google Scholar : PubMed/NCBI | |
Nechuta S, Lu W, Chen Z, Zheng Y, Gu K, Cai H, Zheng W and Shu XO: Vitamin supplement use during breast cancer treatment and survival: A prospective cohort study. Cancer Epidemiol Biomarkers Prev. 20:262–271. 2011. View Article : Google Scholar : PubMed/NCBI | |
Lecumberri E, Dupertuis YM, Miralbell R and Pichard C: Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clin Nutr. 32:894–903. 2013. View Article : Google Scholar : PubMed/NCBI | |
Seely D, Wu P, Fritz H, Kennedy DA, Tsui T, Seely AJ and Mills E: Melatonin as adjuvant cancer care with and without chemotherapy: A systematic review and meta-analysis of randomized trials. Integr Cancer Ther. 11:293–303. 2012. View Article : Google Scholar : PubMed/NCBI | |
Prasad KN and Kumar R: Effect of individual and multiple antioxidant vitamins on growth and morphology of human nontumorigenic and tumorigenic parotid acinar cells in culture. Nutr Cancer. 26:11–19. 1996. View Article : Google Scholar : PubMed/NCBI | |
Jaber S and Polster BM: Idebenone and neuroprotection: Antioxidant, pro-oxidant, or electron carrier? J Bioenerg Biomembr. 47:111–118. 2015. View Article : Google Scholar : PubMed/NCBI | |
Picardo M, Grammatico P, Roccella F, Roccella M, Grandinetti M, Del Porto G and Passi S: Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. J Invest Dermatol. 107:322–326. 1996. View Article : Google Scholar : PubMed/NCBI | |
Rusciani L, Proietti I, Paradisi A, Rusciani A, Guerriero G, Mammone A, De Gaetano A and Lippa S: Recombinant interferon alpha-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: A 3-year trial with recombinant interferon-alpha and 5-year follow-up. Melanoma Res. 17:177–183. 2007. View Article : Google Scholar : PubMed/NCBI | |
Martucci A, Reurean-Pintilei D and Manole A: Bioavailability and sustained plasma concentrations of CoQ10 in healthy volunteers by a novel oral timed-release preparation. Nutrients. 11:5272019. View Article : Google Scholar | |
Lee BJ, Tseng YF, Yen CH and Lin PT: Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: A randomized, placebo-controlled trial. Nutr J. 12:1422013. View Article : Google Scholar : PubMed/NCBI | |
Frontinan-Rubio J, Santiago-Mora RM, Nieva-Velasco CM, Ferrín G, Martínez-González A, Gómez MV, Moreno M, Ariza J, Lozano E, Arjona-Gutiérrez J, et al: Regulation of the oxidative balance with coenzyme Q10 sensitizes human glioblastoma cells to radiation and temozolomide. Radiother Oncol. 128:236–244. 2018. View Article : Google Scholar : PubMed/NCBI | |
Abdulhasan MK, Li Q, Dai J, Abu-Soud HM, Puscheck EE and Rappolee DA: CoQ10 increases mitochondrial mass and polarization, ATP and Oct4 potency levels, and bovine oocyte MII during IVM while decreasing AMPK activity and oocyte death. J Assist Reprod Genet. 34:1595–1607. 2017. View Article : Google Scholar : PubMed/NCBI | |
Awa H, Futamura A, Higashiguchi T, Ito A, Mori N, Murai M, Ohara H, Chihara T and Kaneko T: Effects of combined treatment with branched-chain amino acids, citric acid, L-carnitine, coenzyme Q10, zinc, and various vitamins in tumor-bearing mice. Biol Pharm Bull. 40:266–271. 2017. View Article : Google Scholar : PubMed/NCBI | |
Bahar M, Khaghani S, Pasalar P, Paknejad M, Khorramizadeh MR, Mirmiranpour H and Nejad SG: Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model. Nutr J. 9:622010. View Article : Google Scholar : PubMed/NCBI | |
Qi XF, Kim DH, Yoon YS, Kim SK, Cai DQ, Teng YC, Shim KY and Lee KJ: Involvement of oxidative stress in simvastatin-induced apoptosis of murine CT26 colon carcinoma cells. Toxicol Lett. 199:277–287. 2010. View Article : Google Scholar : PubMed/NCBI | |
Ashkani-Esfahani S, Bagheri F, Emami Y, Esmaeilzadeh E, Azarpira N, Hassanabadi N, Keshtkar M, Farjam M, Koohi-Hosseinabadi O and Noorafshan A: Protective effects of Co-Enzyme Q10 on thioacetamide-induced acute liver damage and its correlation with behavioral, biochemical, and pathological factors. Iran Red Crescent Med J. 18:e291662016. View Article : Google Scholar : PubMed/NCBI | |
Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, et al: Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst. 88:1550–1559. 1996. View Article : Google Scholar : PubMed/NCBI | |
Druesne-Pecollo N, Latino-Martel P, Norat T, Barrandon E, Bertrais S, Galan P and Hercberg S: Beta-carotene supplementation and cancer risk: A systematic review and metaanalysis of randomized controlled trials. Int J Cancer. 127:172–184. 2010. View Article : Google Scholar : PubMed/NCBI | |
Sowmya Shree G, Yogendra Prasad K, Arpitha HS, Deepika UR, Nawneet Kumar K, Mondal P and Ganesan P: β-carotene at physiologically attainable concentration induces apoptosis and down-regulates cell survival and antioxidant markers in human breast cancer (MCF-7) cells. Mol Cell Biochem. 436:1–12. 2017. View Article : Google Scholar : PubMed/NCBI | |
Shultz TD, Chew BP, Seaman WR and Luedecke LO: Inhibitory effect of conjugated dienoic derivatives of linoleic acid and beta-carotene on the in vitro growth of human cancer cells. Cancer Lett. 63:125–133. 1992. View Article : Google Scholar : PubMed/NCBI | |
Mebratu Y and Tesfaigzi Y: How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle. 8:1168–1175. 2009. View Article : Google Scholar : PubMed/NCBI | |
Choi JS, Park SY, Yi EY, Kim YJ and Jeong JW: Coenzyme Q10 decreases basic fibroblast growth factor (bFGF)-induced angiogenesis by blocking ERK activation. Oncol Res. 19:455–461. 2011. View Article : Google Scholar : PubMed/NCBI | |
Zhao Q, Ma YM, Jing L, Zheng TX, Jiang HF, Li PA and Zhang JZ: Coenzyme Q10 protects astrocytes from ultraviolet B-induced damage through inhibition of ERK 1/2 pathway overexpression. Neurochem Res. 44:1755–1763. 2019. View Article : Google Scholar : PubMed/NCBI | |
Shin JY, Choi JW, Kim DG, Zhou ZQ, Shin YK, Seo JH, Song HJ, Choi BM, Bae GS and Park SJ: Protective effects of Coenzyme Q10 against acute pancreatitis. Int Immunopharmacol. 88:1069002020. View Article : Google Scholar : PubMed/NCBI | |
Atay C, Kwak T, Lavilla-Alonso S, Donthireddy L, Richards A, Moberg V, Pilon-Thomas S, Schell M, Messina JL, Rebecca VW, et al: BRAF targeting sensitizes resistant melanoma to cytotoxic T cells. Clin Cancer Res. 25:2783–2794. 2019. View Article : Google Scholar : PubMed/NCBI | |
Pieper N, Zaremba A, Leonardelli S, Harbers FN, Schwamborn M, Lübcke S, Schrörs B, Baingo J, Schramm A, Haferkamp S, et al: Evolution of melanoma cross-resistance to CD8+ T cells and MAPK inhibition in the course of BRAFi treatment. Oncoimmunology. 7:e14501272018. View Article : Google Scholar : PubMed/NCBI | |
Tan BL, Norhaizan ME, Liew WP and Sulaiman Rahman H: Antioxidant and oxidative stress: A mutual interplay in age-related diseases. Front Pharmacol. 9:11622018. View Article : Google Scholar : PubMed/NCBI | |
Jhun J, Lee SH, Byun JK, Jeong JH, Kim EK, Lee J, Jung YO, Shin D, Park SH and Cho ML: Coenzyme Q10 suppresses Th17 cells and osteoclast differentiation and ameliorates experimental autoimmune arthritis mice. Immunol Lett. 166:92–102. 2015. View Article : Google Scholar : PubMed/NCBI | |
Pilipow K, Scamardella E, Puccio S, Gautam S, De Paoli F, Mazza EM, De Simone G, Polletti S, Buccilli M, Zanon V, et al: Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity. JCI Insight. 3:e1222992018. View Article : Google Scholar | |
Molyneux SL, Young JM, Florkowski CM, Lever M and George PM: Coenzyme Q10: Is there a clinical role and a case for measurement? Clin Biochem Rev. 29:71–82. 2008.PubMed/NCBI | |
Toti E, Chen CO, Palmery M, Villaño Valencia D and Peluso I: Non-provitamin A and provitamin A carotenoids as immunomodulators: Recommended dietary allowance, therapeutic index, or personalized nutrition? Oxid Med Cell Longev. 2018:46378612018. View Article : Google Scholar : PubMed/NCBI | |
Bronte E, Bronte G, Novo G, Rinaldi G, Bronte F, Passiglia F and Russo A: Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors. Pharmacol Ther. 192:65–73. 2018. View Article : Google Scholar : PubMed/NCBI |